口服碳水化合物补充剂对硬膜外分娩镇痛产妇剖宫产几率的影响

注册号:

Registration number:

ChiCTR-IOR-17011994 

最近更新日期:

Date of Last Refreshed on:

2021-11-30 05:07:35 

注册时间:

Date of Registration:

2017-07-14 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

口服碳水化合物补充剂对硬膜外分娩镇痛产妇剖宫产几率的影响

Public title:

Effect of oral carbohydrate drink on rate of cesarean delivery in parturients with epidural labor analgesia

注册题目简写:

English Acronym:

研究课题的正式科学名称:

口服碳水化合物补充剂对硬膜外分娩镇痛产妇剖宫产几率的影响:多中心随机开放式研究

Scientific title:

Effect of oral carbohydrate drink on rate of cesarean delivery in parturients with epidural labor analgesia: a multicenter randomized trial

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

丁婷 

研究负责人:

曲元 

Applicant:

Ding Ting 

Study leader:

Qu Yuan 

申请注册联系人电话:

Applicant telephone:

+86 10 83573218

研究负责人电话:

Study leader's
telephone:

+86 10 83573218

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

athena_d@sina.com

研究负责人电子邮件:

Study leader's E-mail:

quyuanbj@hotmail.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市西城区西安门大街1号

研究负责人通讯地址:

北京市西城区西安门大街1号

Applicant address:

1 Xi'anmen Street, Xicheng District, Beijing, China

Study leader's address:

1 Xi'anmen Street, Xicheng District, Beijing, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

北京大学第一院医院麻醉科

Applicant's institution:

Anesthesiology Department of Peking University First Hospital

研究负责人所在单位:

北京大学第一院医院麻醉科

Affiliation of the Leader:

Anesthesiology Department of Peking University First Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2017[1360]

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

北京大学第一医院临床研究伦理委员会

Name of the ethic committee:

Ethics Committee of Peking University First Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2017-06-09 00:00:00

伦理委员会联系人:

于荣辉

Contact Name of the ethic committee:

Yu Ronghui

伦理委员会联系地址:

北京市西城区西安门大街1号

Contact Address of the ethic committee:

1 Xi'anmen Street, Xicheng District, Beijing, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

北京大学第一医院 麻醉科

Primary sponsor:

Anesthesiology Department of Peking University First Hospital

研究实施负责(组长)单位地址:

北京市西城区西安门大街1号

Primary sponsor's address:

1 Xi'anmen Street, Xicheng District, Beijing, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

北京大学第一医院麻醉科

具体地址:

西城区西安门大街1号

Institution
hospital:

Anesthesiology Department of Peking University First Hospital

Address:

1 Xi'anmen Street, Xicheng District

经费或物资来源:

自筹

Source(s) of funding:

self-finance

研究疾病:

剖宫产几率  

Target disease:

rate of cesarean delivery

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

上市后药物 

Study phase:

4

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本多中心研究的主要目的在于进行口服碳水化合物饮料和清亮液体对与接受了硬膜外分娩镇痛产妇剖宫产几率的影响比较。 同时对其他母婴结局(如产程时长,产钳使用几率,母婴产后血糖等)进行研究。  

Objectives of Study:

The purpose of this multicenter trial was to compare the impact of carbohydrate drink versus clear liquid drink on the incidence of cesarean delivery in laboring women with epidural analgesia. And other maternal-fetal outcomes (duration of labor, incidence of forceps delivery, maternal-neonatal blood glucose after delivery, etc.)

药物成份或治疗方案详述:

口服碳水化合物补充剂 

Description for medicine or protocol of treatment in detail:

carbohydrate drink 

纳入标准:

Inclusion criteria

排除标准:

1. 年龄<18岁或者>34岁;
2. 合并糖尿病或者妊娠期糖尿病;
3. 产前B超怀疑胎儿存在异常;
4. 存在硬膜外分娩镇痛禁忌症,这其中包括中枢神经系统疾病病史、脊柱疾病病史、系统性感染(如败血症)、穿刺部位有皮肤/软组织感染、凝血功能异常及其它可能的由麻醉科医生判定的不适于行分娩镇痛的情况;
5. 其他不适于参加实验的情况。

Exclusion criteria:

1.Aged < 18 or > 34 years.
2.Comorbid diabetes mellitus or gestational diabetes mellitus.
3.Suspected fetal abnormalities by prenatal ultrasonography.
4.Presence of contraindications to epidural analgesia (including history of infectious disease of the central nervous system, history of spinal or intraspinal disease, systemic infection, skin or soft tissue infection at the site of puncture, and coagulopathy).
5.Other conditions that were considered unsuitable for study participation.

研究实施时间:

Study execute time:

From 2017-08-01 00:00:00 To 2019-07-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2017-08-01 00:00:00 To 2018-07-01 00:00:00

干预措施:

Interventions:

组别:

术能组

样本量:

1000

Group:

clear fast

Sample size:

干预措施:

产妇在接受了硬膜外分娩镇痛后,给予术能饮料,按需口服

干预措施代码:

Intervention:

After initiating epidural labor analgesia, parturients in the carbohydrate drink group were provided with an oral carbohydrate-rich solution (Outfast: 285 mOsm/kg, 14.2% carbohydrate, 0.58 kcal/ml; Yichang Humanwell Pharmaceutical Co, Ltd, Hubei, China) and were advised to drink as will during labor.

Intervention code:

组别:

清亮液体组

样本量:

1000

Group:

clear liquids

Sample size:

干预措施:

产妇在接受了硬膜外分娩镇痛后给予口服清亮液体(市售运动饮料),按需服用

干预措施代码:

Intervention:

After initiating epidural labor analgesia, Parturients in the clear liquid drink group were advised to intake commercial sports drinks as will (Pocarisweat: 0.26 kcal/ml, Otsuka Pharmaceutical Co. Ltd, Tokyo, Japan; Gatorade, 0.24 kcal/ml, PepsiCo, Chicago, IL, USA; or Mizone: 0.21 kcal/ml, Danone, Guangzhou, Guangdong.

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

浙江 

市(区县):

 

Country:

China

Province:

Zhejiang

City:

单位(医院):

浙江大学附属妇产医院 

单位级别:

三级甲等 

Institution
hospital:

Women's Hospital School of Medicine Zhejiang University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

江苏 

市(区县):

南京 

Country:

China

Province:

Jiangsu

City:

Nanjing

单位(医院):

江苏省妇产医院 

单位级别:

三级甲等 

Institution
hospital:

Obstetrics and Gynecology Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

山东 

市(区县):

临沂 

Country:

China

Province:

Shandong

City:

Linyi

单位(医院):

临沂市人民医院 

单位级别:

三级甲等 

Institution
hospital:

Linyi People's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

安徽 

市(区县):

 

Country:

China

Province:

Anhui

City:

单位(医院):

安徽妇幼保健院 

单位级别:

三级甲等 

Institution
hospital:

Anhui Provincial Women and Chidren Health Care Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

河北 

市(区县):

唐山 

Country:

China

Province:

Hebei

City:

Tangshan

单位(医院):

唐山妇幼保健院 

单位级别:

三级甲等 

Institution
hospital:

Tangshan Women and Chidren Health Care Hospital

Level of the institution:

Tertiary

国家:

中国

省(直辖市):

广西壮族自治区 

市(区县):

 

Country:

China

Province:

Guangxi Zhuang Autonomous Region

City:

单位(医院):

广西壮族自治区妇幼保健院 

单位级别:

三级甲等 

Institution
hospital:

Guangxi Zhuang Autonomous Region Women and Chidren Health Care Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

甘肃 

市(区县):

 

Country:

China

Province:

Gansu

City:

单位(医院):

甘肃妇幼保健院 

单位级别:

三级甲等 

Institution
hospital:

Gansu Women and Chidren Health Care Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

新疆维吾尔自治区 

市(区县):

乌鲁木齐 

Country:

China

Province:

Xinjiang Uyghur Autonomous Region

City:

wulumuqi

单位(医院):

新疆维吾尔自治区妇幼保健院 

单位级别:

三级甲等 

Institution
hospital:

Xinjiang Uyghur Autonomous Region Women and Chidren Health Care Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

china

Province:

Beijing

City:

单位(医院):

北京大学第一医院 

单位级别:

三级甲等 

Institution
hospital:

Peking University First Hospital

Level of the institution:

Teritary A

测量指标:

Outcomes:

指标中文名:

剖宫产几率

指标类型:

主要指标

Outcome:

The rate of cesarean delivery.

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

产程时长

指标类型:

次要指标

Outcome:

Duration of labor.

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

产钳几率

指标类型:

次要指标

Outcome:

Rate of forceps delivery

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

产妇产后饥饿、口渴评分

指标类型:

次要指标

Outcome:

The NRS score of hunger/thirst

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

母亲产后血糖

指标类型:

次要指标

Outcome:

Maternal blood glucose after giving birth

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

1/5分钟apgar评分

指标类型:

次要指标

Outcome:

1- and 5-minute Apgar scores

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

脐动脉血气ph值

指标类型:

次要指标

Outcome:

The umbilical artery pH value

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

新生儿生后血糖

指标类型:

次要指标

Outcome:

Neonatal blood glucose after birth

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

新生儿入NICU几率

指标类型:

次要指标

Outcome:

The rate of neonatal ward admission.

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

产程中恶心呕吐几率

指标类型:

副作用指标

Outcome:

Vomiting during labor

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

剖宫产时恶心呕吐几率

指标类型:

副作用指标

Outcome:

Vomiting during cesarean delivery

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

产妇心动过缓

指标类型:

副作用指标

Outcome:

Bradycardia

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

产妇低血压

指标类型:

副作用指标

Outcome:

Hypotension during labor

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

产妇产后高血糖

指标类型:

副作用指标

Outcome:

Maternal hyperglycemia

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

产妇产后低血糖

指标类型:

副作用指标

Outcome:

Maternal hypoglycemia

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

新生儿高血糖

指标类型:

副作用指标

Outcome:

Neonatal hyperglycemia

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

新生儿低血糖

指标类型:

副作用指标

Outcome:

Neonatal hypoglycemia

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

女性

Gender:

Female

随机方法(请说明由何人用什么方法产生随机序列):

SAS统计软件包 (SAS 9.2, SAS Institute Inc. USA, North Carolina)

Randomization Procedure (please state who generates the random number sequence and by what method):

SAS statistical package (SAS 9.2, SAS Institute Inc. USA, North Carolina)

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

开放(产后评估者盲)

Blinding:

open-label(outcome assessor blind)

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

北京大学第一医院 请阅读网页注册指南中关于 原始数据共享 的内容。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Peking University First Hospital

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF表记录,EDC管理,REDCap数据库

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF EDC REDCap database

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2017-07-14 22:03:17